Insider Transactions in Q1 2024 at Century Therapeutics, Inc. (IPSC)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 07
2024
|
Brent Pfeiffenberger President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
17,425
+1.17%
|
-
|
|
Mar 07
2024
|
Adrienne Farid Chief Operations Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+14.8%
|
-
|
|
Mar 07
2024
|
Gregory Russotti Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+7.35%
|
-
|
|
Mar 07
2024
|
Douglas Carr SVP Finance & Operations |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+4.22%
|
-
|
|
Mar 07
2024
|
Hyam Levitsky President of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+50.0%
|
-
|
|
Mar 07
2024
|
Adrienne Farid Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
22,831
-16.67%
|
$114,155
$5.14 P/Share
|
|
Mar 07
2024
|
Adrienne Farid Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,831
+14.29%
|
$22,831
$1.03 P/Share
|
|
Mar 06
2024
|
Adrienne Farid Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
30,684
-21.19%
|
$122,736
$4.96 P/Share
|
|
Mar 06
2024
|
Adrienne Farid Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,684
+17.48%
|
$30,684
$1.03 P/Share
|
|
Feb 16
2024
|
Adrienne Farid Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
485
-0.42%
|
$1,940
$4.86 P/Share
|
|
Feb 16
2024
|
Adrienne Farid Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
485
+0.42%
|
$485
$1.03 P/Share
|
|
Feb 06
2024
|
Adrienne Farid Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
1,784
-1.54%
|
$7,136
$4.49 P/Share
|
|
Feb 06
2024
|
Douglas Carr SVP Finance & Operations |
SELL
Open market or private sale
|
Direct |
557
-0.18%
|
$2,228
$4.49 P/Share
|
|
Feb 05
2024
|
Adrienne Farid Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
2,035
-1.73%
|
$6,105
$3.84 P/Share
|
|
Feb 05
2024
|
Douglas Carr SVP Finance & Operations |
SELL
Open market or private sale
|
Direct |
643
-0.21%
|
$1,929
$3.84 P/Share
|